Introduction: Hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) is the most common subtype in postmenopausal women (1). Endocrine therapy, especially aromatase inhibitors (AIs), is the standard first-line treatment due to its effectiveness and tolerability (1). However, resistanc
Female with History of Amenorrhoea
3096 Reached10 Comments11 Likes
Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes
FOURIER Trial: Efficacy of Evolocumab in Managing Cardiovascular Events
563 Reached3 Comments
Study evaluating Effectiveness of Bacillus clausii for Treatment of Rotavirus Infection
1303 Reached4 Comments6 Likes
Vildagliptin in Reducing Risk of Post-partum Diabetes
2385 Reached7 Comments4 Likes